A detailed history of Rogco, LP transactions in Biogen Inc. stock. As of the latest transaction made, Rogco, LP holds 19 shares of BIIB stock, worth $3,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 19 -0.0%
Holding current value
$3,442
Previous $4.41 Million 16.39%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $36,198 - $44,976
-190 Reduced 90.91%
19 $4.41 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $52,939 - $59,751
209 New
209 $53.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Rogco, LP Portfolio

Follow Rogco, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rogco, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rogco, LP with notifications on news.